A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation

Journal of Neuroscience Methods

Volumn 81, Issue 1-2, 1998, Pages 19-24

  Johnson, Kirk W ^a   Phebus, Lee A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antidromic; CP 122,288; Electrical; Evans blue; Fluorescence photomicroscopy; Migraine; Sumatriptan

Indexed keywords

5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; EVANS BLUE; PLASMA PROTEIN; SUMATRIPTAN; SUMATRIPTAN SUCCINATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DURA MATER; ELECTROSTIMULATION; EXTRAVASATION; FLUORESCENCE SPECTROSCOPY; GUINEA PIG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; TRIGEMINUS GANGLION;

ANIMALS; BIOLOGICAL TRANSPORT; DURA MATER; ELECTRIC STIMULATION; EVANS BLUE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FLUORESCENCE; GUINEA PIGS; INFLAMMATION; INJECTIONS, INTRAVENOUS; MALE; MICROSCOPY, FLUORESCENCE; MICROSPECTROPHOTOMETRY; MIGRAINE DISORDERS; PROTEIN BINDING; PROTEINS; PYRROLIDINES; SUMATRIPTAN; TRIGEMINAL GANGLION;

EID: 0032101096     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(98)00010-7     Document Type: Article

References (27)

1. Allen TH, Dralpvats PD. Spectrophotometric measurement of traces of the dye T-1824 by extraction with cellophane from both blood serum and urine of normal dogs. Am J Physiol 1948;154:27-38.
2. Buzzi MG, Bonamini M, Moskowitz MA. Neurogenic model of migraine. Cephalalgia 1995;15:277-80.
3. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990;99:202-6.
4. Buzzi MG, Moskowitz MA, Peroutka SJ, Byun B. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol 1991;103:1421-8.
5. Buzzi MG, Sakas DE, Moskowitz MA. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 1989;165:251-8.
6. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
7. Gupta P, Brown D, Butler P, Ellis P, Grayson KL, Land GC, Macor JE, Robson SF, Wythes MJ, Shepperson NB. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Br J Pharmacol 1995;116:2385-90.
8. Hardebo JE. The involvement of trigeminal substance P neurons in cluster headache. An hypothesis. Headache 1984;24:294-304.
9. Huang Z, Byun B, Matsubara T, Moskowitz MA. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11. Br J Pharmacol 1993;108:331-5.
10. Lee WS, Moskowitz MA. Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res 1993;626:303-5.
11. Lee WS, Moussaoui SM, Moskowitz MA. Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva. Br J Pharmacol 1994;112:920-4.
12. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979;310:175-83.
13. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987;7:4129-36.
14. Mayberg MR, Zervas NT, Moskowitz MA. Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol 1984;223:46-56.
15. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16:157-68.
16. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-11.
17. Moskowitz MA, Reinhard J Jr., Romero J, Melamed E, Pettibone DJ. Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 1979;2:883-5.
18. Moussaoui SM, Philippe L, Le Prado N, Garret C. Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. Eur J Pharmacol 1993;238:421-4.
19. O'Shaughnessy CT, Connor HE. Neurokinin NK1 receptors mediate plasma protein extravasation in guinea-pig dura. Eur J Pharmacol 1993;236:319-21.
20. O'Shaughnessy CT, Connor HE. Investigation of the role of tachykinin NK1, NK2 receptors and CGRP receptors in neurogenic plasma protein extravasation in dura mater. Eur J Pharmacol 1994;263:193-8.
21. Rawson RA. The binding of T-1824 and structurally related diazo dyes by plasma proteins. Am J Physiol 1943;138:708-17.
22. Saito K, Markowitz S, Moskowitz MA. Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 1988;24:732-7.
23. Saria A, Gamse R, Lundberg JM, Hokfelt T, Theodorsson-Norheim E, Peterman J, Fischer JA. Coexistence of tachykinins and calcitonin gene-related peptide in sensory nerves in relation to neurogenic inflammation. In: Hakanson R, Sundler F, editors. Tachykinin Antagonists. New York: Elsevier Science Publishing, 1985:149-57.
24. Saria A, Gamse R, Petermann J, Fischer JA, Theodorsson-Norheim E, Lundberg JM. Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett 1986;63:310-4.
25. Shepheard SL, Williamson DJ, Hill RG, Hargreaves RJ. The nonpeptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol 1993;108:11-2.
26. Shepheard SL, Williamson DJ, Williams J, Hill RG, Hargreaves RJ. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 1995;34:255-61.
27. Steiger HJ, Tew J Jr., Keller JT. The sensory representation of the dura mater in the trigeminal ganglion of the cat. Neurosci Lett 1982;31:231-6.